Annual EBIT
-$48.30 M
-$20.94 M-76.52%
December 31, 2023
Summary
- As of February 8, 2025, MXCT annual earnings before interest & taxes is -$48.30 million, with the most recent change of -$20.94 million (-76.52%) on December 31, 2023.
- During the last 3 years, MXCT annual EBIT has fallen by -$37.31 million (-339.45%).
- MXCT annual EBIT is now -6417.20% below its all-time high of -$741.10 thousand, reached on December 31, 2015.
Performance
MXCT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$14.05 M
-$2.08 M-17.42%
September 30, 2024
Summary
- As of February 8, 2025, MXCT quarterly earnings before interest & taxes is -$14.05 million, with the most recent change of -$2.08 million (-17.42%) on September 30, 2024.
- Over the past year, MXCT quarterly EBIT has dropped by -$101.00 thousand (-0.72%).
- MXCT quarterly EBIT is now -492.68% below its all-time high of -$2.37 million, reached on December 31, 2020.
Performance
MXCT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$46.39 M
-$101.00 K-0.22%
September 30, 2024
Summary
- As of February 8, 2025, MXCT TTM earnings before interest & taxes is -$46.39 million, with the most recent change of -$101.00 thousand (-0.22%) on September 30, 2024.
- Over the past year, MXCT TTM EBIT has increased by +$561.70 thousand (+1.20%).
- MXCT TTM EBIT is now -1533.87% below its all-time high of -$2.84 million, reached on June 30, 2020.
Performance
MXCT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MXCT EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -76.5% | -0.7% | +1.2% |
| 3 y3 years | -339.4% | -108.2% | -69.6% |
| 5 y5 years | -485.1% | -108.2% | -69.6% |
MXCT EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -167.8% | at low | -237.9% | at low | -193.0% | +4.0% |
| 5 y | 5-year | -339.4% | at low | -492.7% | at low | -1533.9% | +4.0% |
| alltime | all time | -6417.2% | at low | -492.7% | at low | -1533.9% | +4.0% |
MaxCyte EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$14.05 M(+17.4%) | -$46.39 M(+0.2%) |
| Jun 2024 | - | -$11.97 M(-2.5%) | -$46.29 M(-2.3%) |
| Mar 2024 | - | -$12.28 M(+51.6%) | -$47.40 M(-1.9%) |
| Dec 2023 | -$48.30 M(+76.5%) | -$8.10 M(-42.0%) | -$48.30 M(+2.9%) |
| Sep 2023 | - | -$13.95 M(+6.7%) | -$46.95 M(+15.3%) |
| Jun 2023 | - | -$13.07 M(-0.8%) | -$40.71 M(+11.9%) |
| Mar 2023 | - | -$13.18 M(+95.2%) | -$36.38 M(+33.0%) |
| Dec 2022 | -$27.36 M(+51.7%) | -$6.75 M(-12.5%) | -$27.36 M(+7.4%) |
| Sep 2022 | - | -$7.71 M(-11.7%) | -$25.48 M(+26.4%) |
| Jun 2022 | - | -$8.74 M(+110.1%) | -$20.16 M(+27.3%) |
| Mar 2022 | - | -$4.16 M(-14.7%) | -$15.83 M(-12.2%) |
| Dec 2021 | -$18.04 M | -$4.87 M(+103.8%) | -$18.04 M(+16.1%) |
| Sep 2021 | - | -$2.39 M(-45.8%) | -$15.53 M(-2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$4.41 M(-30.7%) | -$15.98 M(+10.9%) |
| Mar 2021 | - | -$6.36 M(+168.4%) | -$14.41 M(+79.1%) |
| Dec 2020 | -$10.99 M(-10.0%) | -$2.37 M(-16.4%) | -$8.05 M(+41.8%) |
| Sep 2020 | - | -$2.84 M(-0.1%) | -$5.67 M(+99.9%) |
| Jun 2020 | - | -$2.84 M | -$2.84 M |
| Dec 2019 | -$12.21 M(+48.0%) | - | - |
| Dec 2018 | -$8.25 M(-11.2%) | - | - |
| Dec 2017 | -$9.29 M(+243.2%) | - | - |
| Dec 2016 | -$2.71 M(+265.4%) | - | - |
| Dec 2015 | -$741.10 K(-41.9%) | - | - |
| Dec 2014 | -$1.28 M(+58.5%) | - | - |
| Dec 2013 | -$804.70 K(-58.2%) | - | - |
| Dec 2012 | -$1.93 M | - | - |
FAQ
- What is MaxCyte annual earnings before interest & taxes?
- What is the all time high annual EBIT for MaxCyte?
- What is MaxCyte annual EBIT year-on-year change?
- What is MaxCyte quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for MaxCyte?
- What is MaxCyte quarterly EBIT year-on-year change?
- What is MaxCyte TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for MaxCyte?
- What is MaxCyte TTM EBIT year-on-year change?
What is MaxCyte annual earnings before interest & taxes?
The current annual EBIT of MXCT is -$48.30 M
What is the all time high annual EBIT for MaxCyte?
MaxCyte all-time high annual earnings before interest & taxes is -$741.10 K
What is MaxCyte annual EBIT year-on-year change?
Over the past year, MXCT annual earnings before interest & taxes has changed by -$20.94 M (-76.52%)
What is MaxCyte quarterly earnings before interest & taxes?
The current quarterly EBIT of MXCT is -$14.05 M
What is the all time high quarterly EBIT for MaxCyte?
MaxCyte all-time high quarterly earnings before interest & taxes is -$2.37 M
What is MaxCyte quarterly EBIT year-on-year change?
Over the past year, MXCT quarterly earnings before interest & taxes has changed by -$101.00 K (-0.72%)
What is MaxCyte TTM earnings before interest & taxes?
The current TTM EBIT of MXCT is -$46.39 M
What is the all time high TTM EBIT for MaxCyte?
MaxCyte all-time high TTM earnings before interest & taxes is -$2.84 M
What is MaxCyte TTM EBIT year-on-year change?
Over the past year, MXCT TTM earnings before interest & taxes has changed by +$561.70 K (+1.20%)